Neuralink has announced a backlog of 10,000 patients eager to receive its brain implant technology, highlighting significant interest and demand for the company's innovations in neurotechnology. The firm is working to navigate regulatory hurdles as it aims to expand its clinical trials and bring the implant to market.

Neurotech startup Paradromics has successfully implanted its brain-computer interface in a human for the first time during a neurosurgery procedure at the University of Michigan. The Connexus Brain-Computer Interface aims to assist patients with severe motor impairments, and the company plans to initiate clinical trials pending regulatory approval. Paradromics is part of a growing field of BCI technology development, alongside other notable companies like Neuralink and Synchron.